Testing for SIADH (the syndrome of inappropriate antidiuretic hormone secretion) relies on a specific sequence of blood and urine lab tests rather than any single definitive marker. The diagnosis is built by layering results: low serum sodium and low serum osmolality first, then urine osmolality and urine sodium to show the kidneys are concentrating urine when they should not be, and finally a round of exclusion tests to rule out other conditions that mimic the same pattern. About 30% of hospitalized patients have low sodium, and SIADH is one of the most common reasons for it, so getting the diagnostic workup right matters.
Serum Sodium and Serum Osmolality Come First
The workup begins with basic blood draws. A serum sodium level below the normal range (roughly 136–145 mmol/L) flags hyponatremia. But low sodium alone does not point to SIADH; it could reflect dozens of different problems. The next critical measurement is serum osmolality, which tells you how concentrated the blood is overall. In SIADH, serum osmolality falls below about 280 mOsm/kg because the body is holding on to too much water, diluting everything in the bloodstream.1PubMed Central. The hyponatremic patient: a systematic approach to laboratory diagnosis
If the effective serum osmolality comes back normal or elevated despite the low sodium reading, clinicians look for pseudohyponatremia instead. This happens when high blood glucose pulls water out of cells into the bloodstream, diluting sodium artificially. In patients with uncontrolled diabetes, for instance, the sodium level can look deceptively low even though the body’s actual sodium balance is fine. A correction formula that accounts for the elevated glucose helps clinicians tell the difference.2Evidence to Action: Official Journal of MDCalc. Sodium Correction for Hyperglycemia Extremely high levels of triglycerides or proteins in the blood can also produce misleadingly low sodium readings on older lab analyzers, so those possibilities need to be considered before moving forward with a SIADH workup.
Urine Osmolality Reveals the Problem
Once you have confirmed that the blood is genuinely dilute (low serum osmolality), the next question is whether the kidneys are responding appropriately. Normally, when the blood is dilute, the kidneys should produce very watery urine to get rid of excess fluid. In SIADH, the kidneys do the opposite: they keep concentrating urine even though the body does not need to conserve water. This is the “inappropriate” part of the syndrome’s name.
Urine osmolality is the test that catches this misbehavior. A urine osmolality above 100 mOsm/L in the setting of low serum osmolality is considered inappropriately elevated and consistent with SIADH.3PubMed Central. Clinical Approach to Euvolemic Hyponatremia In practice, the value is often much higher, sometimes several hundred mOsm/L, because antidiuretic hormone (ADH, also called vasopressin) is telling the kidneys to reabsorb water aggressively. If urine osmolality is very low, the kidneys are excreting water normally, and SIADH is essentially off the table. Something else, like excessive water intake (psychogenic polydipsia) or a very low-solute diet, would be the more likely culprit.
Urine Sodium Helps Separate SIADH from Volume Depletion
Urine sodium concentration is one of the more useful parts of the workup because it helps distinguish SIADH from hyponatremia caused by dehydration or fluid loss. In SIADH, the kidneys excrete sodium freely because the body perceives its volume as normal or slightly expanded. Urine sodium is typically elevated, and some cases show strikingly high values above 130 mmol/L.4PubMed Central. High Urinary Sodium Concentrations in Severe SIADH: Case Reports of 2 Patients and Literature Review In contrast, when someone is volume-depleted (say from vomiting or diarrhea), the kidneys hang on to every bit of sodium they can, so urine sodium drops low.
A commonly cited threshold is a urine sodium above 40 mmol/L as suggestive of SIADH, though in one study that specifically evaluated diagnostic accuracy, a cutoff of 50 mEq/L was the most accurate at separating SIADH from hypovolemic hyponatremia, with a sensitivity of 0.89 and an overall accuracy of 0.82.5PubMed Central. Diagnostic value of urine sodium concentration in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion versus hypovolemia The test is not perfect on its own, which is why it is always interpreted alongside serum osmolality and urine osmolality rather than in isolation.
Blood Urea Nitrogen and Serum Uric Acid
Two blood markers that do not always get headline attention but provide meaningful supporting evidence are blood urea nitrogen (BUN) and serum uric acid. Both tend to run low in SIADH because the excess water dilutes them and because the expanded blood volume increases their clearance through the kidneys.
BUN in SIADH typically falls in the range of about 3 to 10 mg/dL, well below the normal range for most adults.6PubMed Central. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan That said, a low urea is less specific in older patients, whose kidneys clear urea more slowly and may maintain higher urea levels even in the presence of SIADH.7Clinical Journal of the American Society of Nephrology. Clinical Laboratory Evaluation of the Syndrome of Inappropriate Secretion of Antidiuretic Hormone
Serum uric acid also tends to drop in SIADH because the kidneys ramp up uric acid excretion. On its own, a low uric acid level just adds a supporting clue. Where it gets more useful is when you calculate the fractional excretion of uric acid (the percentage of filtered uric acid that ends up in the urine), which can help sort SIADH from look-alike conditions, especially in patients who are on diuretics.
The Diuretic Problem and Fractional Excretion of Uric Acid
Diagnosing SIADH in someone who takes diuretics is genuinely tricky. Diuretics, particularly thiazide-type drugs, can cause low sodium on their own. They also push sodium into the urine, which makes the classic “high urine sodium” criterion for SIADH unreliable. If the patient takes a thiazide and shows up with hyponatremia and concentrated urine, the standard lab criteria cannot confidently say whether SIADH is present or whether the diuretic is doing all the work.8The Journal of Clinical Endocrinology & Metabolism. Value of Fractional Uric Acid Excretion in Differential Diagnosis of Hyponatremic Patients on Diuretics
This is where fractional excretion of uric acid (FE-UA) proves its worth. One study found that FE-UA had an area under the curve of 0.96 for distinguishing SIADH from diuretic-induced hyponatremia, with a positive predictive value of 100% when a cutoff of 12% was used.9The Journal of Clinical Endocrinology & Metabolism. Value of Fractional Uric Acid Excretion in Differential Diagnosis of Hyponatremic Patients on Diuretics The reasoning is straightforward: in SIADH, the kidneys excrete uric acid at a high rate because the expanded volume drives clearance. Diuretics do not have the same effect on uric acid excretion, so FE-UA stays lower in diuretic-induced hyponatremia. In another study, FE-UA discriminated between SIADH and diuretic-induced hyponatremia much better than serum uric acid alone.10PubMed Central. The Role of Fractional Excretion of Uric Acid in the Differential Diagnosis of Hypotonic Hyponatraemia in Patients with Diuretic Therapy For patients on diuretics, combining urine sodium with FE-UA gives the most reliable picture.
What Has to Be Ruled Out Before Diagnosing SIADH
SIADH is fundamentally a diagnosis of exclusion. Even if the blood and urine tests fit the classic pattern, clinicians need to confirm that nothing else is driving the low sodium. Two conditions sit at the top of the must-exclude list: hypothyroidism and adrenal insufficiency. Both can produce hyponatremia that looks nearly identical to SIADH on standard labs, and both are treatable with hormone replacement. A thyroid panel and a cortisol level (often a morning cortisol or a cosyntropin stimulation test) are standard parts of the workup.3PubMed Central. Clinical Approach to Euvolemic Hyponatremia
Medication review is equally important. Dozens of drugs can trigger SIADH-like lab findings, including certain antidepressants (SSRIs are common culprits), anticonvulsants like carbamazepine, some chemotherapy agents, and nonsteroidal anti-inflammatory drugs. Stopping the offending medication and watching whether sodium corrects is sometimes the most informative “test” in the entire workup. Diuretic use needs to be documented for the reasons discussed above.
Volume status assessment is the clinical piece that ties the labs together. SIADH patients look clinically euvolemic: no signs of dehydration (dry mucous membranes, low blood pressure on standing) and no signs of fluid overload (swelling, elevated jugular venous pressure). If the patient looks volume-depleted, the hyponatremia more likely reflects true fluid loss. If they look overloaded, heart failure, liver cirrhosis, or kidney disease are the usual suspects. Neither of those patterns fits SIADH.11PubMed Central. Syndrome of inappropriate antidiuretic hormone secretion: Revisiting a classical endocrine disorder
Distinguishing SIADH from Cerebral Salt Wasting
In patients with brain injuries, neurosurgery, or central nervous system infections, a particularly confusing diagnostic overlap arises between SIADH and cerebral salt-wasting syndrome (CSW). Both produce low sodium and high urine sodium. The critical distinction is volume: SIADH patients are euvolemic or slightly volume-expanded, while CSW patients are volume-depleted because their kidneys are actively wasting sodium and pulling water along with it. CSW patients tend to produce much larger urine volumes and excrete more sodium than SIADH patients.12Frontiers in Neuroscience. Inappropriate Antidiuretic Hormone Secretion and Cerebral Salt-Wasting Syndromes in Neurological Patients
The distinction matters because treatment is opposite: SIADH is managed with fluid restriction, while CSW requires fluid and sodium replacement. Unfortunately, assessing volume status at the bedside is imprecise. Surrogate markers like central venous pressure, urine output trends, hematocrit changes, and BUN-to-creatinine ratios are used but can be misleading. Some centers use serial body weight measurements as a practical proxy: weight gain suggests SIADH, weight loss suggests CSW. Even so, in neurological patients this remains one of the most debated differential diagnoses in electrolyte medicine.
Copeptin as a Newer Biomarker
Directly measuring ADH (vasopressin) in the blood would seem like the obvious way to confirm SIADH, but in practice it is unreliable. Vasopressin is unstable in blood samples, breaks down quickly, and sticks to platelets, making accurate measurement a technical headache. This is why clinicians have historically relied on the indirect evidence (urine and serum labs) rather than measuring the hormone itself.
Copeptin, a protein fragment that is released in equal amounts alongside vasopressin but remains stable in blood, has emerged as a potential workaround.13Nature Reviews Endocrinology. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis Measuring copeptin gives you a reliable proxy for vasopressin secretion. One study used copeptin to categorize SIADH patients by their underlying pattern of hormone release and found considerable variety: about 10% had copeptin levels that stayed grossly elevated regardless of blood concentration, 14% had a low set point for triggering vasopressin release, 44% had normal copeptin levels despite clinical SIADH, and 12% had suppressed copeptin.14PubMed Central. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis
That variety hints at why SIADH is not a single disease but a collection of different malfunctions in water balance. In clinical practice, though, copeptin is not yet a standard diagnostic tool. Research has explored whether the ratio of copeptin to urine sodium could help distinguish SIADH from volume-depleted states, but copeptin alone was not enough, and more studies are needed before it becomes a routine part of the workup.15Frontiers in Endocrinology. Copeptin analysis in endocrine disorders – Section: 3.2 Syndrome of inappropriate antidiuretic hormone
Searching for the Underlying Cause
Confirming SIADH through lab tests is only half the job. The syndrome is almost always triggered by something else: a medication, a lung condition, a central nervous system disorder, or a malignancy. Finding that trigger determines long-term management. In older adults, the cause remains unknown in a surprisingly large proportion of cases. One study of elderly patients found that 60% of SIADH cases were idiopathic, with pneumonia (18%) and medications (12%) being the next most common identifiable causes.16PubMed. The syndrome of inappropriate antidiuretic hormone secretion in the elderly
The typical workup to find a cause includes a chest X-ray or CT scan (since small-cell lung cancer is a well-known trigger), brain imaging if a central nervous system cause is suspected, and a thorough medication review. In one case report, a mediastinal tumor was discovered on chest CT after the initial brain and abdominal imaging came back clean.17PubMed Central. Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Mediastinal Schwannoma This illustrates why imaging beyond a simple chest X-ray can be valuable, particularly when no obvious drug or infection explains the syndrome.
Age-Related Challenges in Diagnosis
Older adults present a unique diagnostic challenge with SIADH. Aging changes the body’s handling of water and sodium in ways that blur the usual lab cutoffs. Kidney function declines, thirst mechanisms weaken, and many older patients take multiple medications that affect sodium balance. The baseline serum sodium in an older person may already sit at the low end of normal, and mild SIADH can persist for months without causing obvious symptoms.
In one study of patients in a geriatric unit, a quarter had hyponatremia, and half of those cases were caused by SIADH. In about 40% of the SIADH group, no cause could be found. Several of these patients had chronic, mild hyponatremia lasting anywhere from 12 to 72 months with sodium levels hovering between 128 and 135 mmol/L.18PubMed Central. Chronic idiopathic hyponatremia in older people due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) possibly related to aging That chronic low-grade pattern can fly under the radar because the symptoms (fatigue, mild confusion, unsteadiness) overlap with so many other conditions in older people. Meanwhile, the supporting markers like BUN are less reliable in this age group, as noted earlier, because age-related kidney changes keep BUN higher than expected for SIADH.
The Water Load Test and Reset Osmostat
Not every case of SIADH behaves the same way, and one particular variant called “reset osmostat” can be difficult to pin down with standard labs alone. In reset osmostat, the body’s thermostat for sodium regulation is set at a lower-than-normal level. The person maintains a stable but low sodium without the progressive worsening seen in other forms of SIADH. Standard labs may show the classic SIADH pattern, but the sodium stays constant rather than drifting further downward.
A water load test can help identify this variant. The patient drinks a measured amount of water (typically about 20 mL per kilogram of body weight), and clinicians track how much of it the kidneys excrete over the next few hours. In reset osmostat, the kidneys will excrete the water load normally and serum sodium will remain stable. In other forms of SIADH, the kidneys retain the water and the sodium drops further.19Endocrine Reviews. Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management The practical importance of distinguishing reset osmostat from other forms is that it can sometimes be left alone, since the sodium stays stable and the patient may be asymptomatic. This test is rarely used as a first-line diagnostic step, but it fills an important gap when the clinical picture does not add up.
Putting the Pieces Together in Practice
No single lab result diagnoses SIADH. The diagnosis comes together as a pattern across multiple tests, each ruling out an alternative explanation and reinforcing the case for inappropriate water retention. In practice, the workup follows a logical cascade:
- Serum sodium and osmolality: Confirms genuine hypo-osmolar hyponatremia and excludes pseudohyponatremia from high glucose, lipids, or proteins.
- Urine osmolality: Demonstrates inappropriately concentrated urine (above 100 mOsm/L) when the blood is dilute.
- Urine sodium: Elevated levels (generally above 40–50 mmol/L) help separate SIADH from volume-depleted states.
- Thyroid and cortisol levels: Exclude hypothyroidism and adrenal insufficiency, two treatable mimics.
- BUN, creatinine, uric acid: Low values provide supporting evidence and help exclude kidney disease.
- Fractional excretion of uric acid: Particularly valuable in patients taking diuretics, where standard urine sodium is unreliable.
- Clinical volume assessment: Euvolemic status on exam is essential; signs of dehydration or fluid overload point elsewhere.
Timing matters for these tests. Ideally, blood and urine samples are collected before any treatment is started, since intravenous fluids or fluid restriction will alter the results. Paired serum and urine specimens (drawn and collected at the same time) give the most interpretable data. If the patient is already receiving IV saline, the urine sodium and osmolality readings may no longer reflect the underlying disorder accurately. Similarly, specimens for cortisol testing should be drawn in the morning when cortisol naturally peaks, and the cosyntropin stimulation test has its own timing protocol that needs to be followed precisely. Rushing into treatment before labs are drawn is a common practical error that can make the diagnosis harder to confirm after the fact.